サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1375086

北米のドラッグデリバリー市場の2028年予測-地域別分析-投与経路、流通チャネル、エンドユーザー別

North America Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Route of Administration, Distribution Channel, and End User

出版日
ページ情報
英文 233 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
北米のドラッグデリバリー市場の2028年予測-地域別分析-投与経路、流通チャネル、エンドユーザー別
出版日: 2023年08月21日
発行: The Insight Partners
ページ情報: 英文 233 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のドラッグデリバリー市場は、2023年の9,746億3,953万米ドルから2028年には1兆4,294億1,779万米ドルに成長すると予測されています。2023年から2028年までのCAGRは8.0%と推定されます。

慢性疾患の増加が北米ドラッグデリバリー市場を牽引

米国疾病予防管理センター（CDC）によると、米国では10人に6人が少なくとも1つの慢性疾患に罹患しており、2019年時点では10人に4人が2つ以上の慢性疾患に罹患しています。慢性的な病状に苦しむ患者は時間とともに悪化し、患者の家族や社会に多大な負担をもたらします。米国がん協会（ACS）の予測によると、米国では2023年に約195万8,310人の新規がん患者と60万9,820人の死亡者を記録する可能性があります。糖尿病は生命を脅かす慢性疾患であり、特効薬はないです。すべてのタイプの糖尿病は、体のさまざまな部位にさまざまな合併症を引き起こし、早死のリスクを高める。心臓発作、脳卒中、腎不全、脚の切断、視力低下、神経損傷がこの病気に伴う主な合併症です。糖尿病の症例は世界中で著しく増加しています。

慢性疾患の有病率の増加は、過去数十年間におけるドラッグデリバリーの集中的な研究開発（R&D）を促進しました。慢性疾患の治療に使用される薬剤の治療効果は、ナノ粒子（セラミック、ポリマー、金属など）、ミセル、リポソーム、デンドリマーなどの最適なドラッグデリバリーによって向上させることができます。ドラッグデリバリーを用いた薬剤の投与は、薬剤の全身的な副作用を軽減するのにも役立ちます。糖尿病、がん、アテローム性動脈硬化症、心筋虚血、喘息、肺結核、パーキンソン病、アルツハイマー病などの幅広い慢性疾患に対して、治療薬を標的を定めてコントロールしながらデリバリーするために、さまざまなドラッグデリバリーが導入されています。適切なドラッグデリバリーは、長期間にわたって高い薬物バイオアベイラビリティを確保することで、あらゆる薬物の治療効果を高めます。標的ドラッグデリバリー（TDDS）は、被験者の体内のあらかじめ選択された部位に、制御された方法で薬物を放出します。ナノ技術に基づく送達システムは、がん治療に大きなインパクトを与えており、ポリマーはこれらのナノ粒子キャリアの開発において重要な役割を果たしています。投与経路の多様性に加え、ナノ治療薬デリバリー（NDDS）の注目すべき技術的利点として、半減期の延長、生体内分布の改善、薬物循環時間の延長、薬物放出の制御と持続、細胞間薬物濃度の上昇などが挙げられます。

これらの疾患の慢性的な性質を考慮すると、慢性疾患の患者は継続的な薬物治療に依存しており、副作用の継続的なリスクと関連しています。標的薬剤のための適切なデリバリーを開発することは、病原性病変における標的薬剤の蓄積を促進し、全身的な副作用を軽減し、患者の転帰を改善することができます。このように、慢性疾患や生活習慣病の増加が北米のドラッグデリバリー市場の成長を後押ししています。

北米ドラッグデリバリー市場概要

北米はドラッグデリバリーの最大市場であり、米国が最大の市場シェアを占め、カナダがこれに続く。北米の市場成長の特徴は、バイオ製薬・バイオテクノロジー企業による希少疾患治療薬の需要増加、主要市場参入企業の存在、さまざまな学術・研究機関による広範な研究開発です。また、製薬企業やバイオテクノロジー企業における広範な調査が、予測期間中の北米におけるドラッグデリバリー市場の成長をサポートすると予想されます。

北米のドラッグデリバリー市場の収益と2028年までの予測（金額）

北米のドラッグデリバリー市場セグメンテーション

北米のドラッグデリバリー市場は、投与経路、流通チャネル、エンドユーザー、国別に区分されます。

投与経路に基づき、北米のドラッグデリバリー市場は、注射薬デリバリー、経口薬デリバリー、経粘膜薬デリバリー、局所薬デリバリー、移植薬デリバリー、眼薬デリバリーに区分されます。2023年の北米ドラッグデリバリー市場では、注射薬デリバリー分野が最大のシェアを占めています。

北米のドラッグデリバリー市場は、流通チャネル別に病院薬局、小売薬局、オンライン薬局に区分されます。2023年の北米ドラッグデリバリー市場では、病院薬局セグメントが最大のシェアを占めています。

エンドユーザー別に見ると、北米のドラッグデリバリー市場は病院・クリニック、在宅医療現場、その他のエンドユーザーに区分されます。2023年の北米ドラッグデリバリー市場では、病院・クリニックセグメントが最大のシェアを占めています。

国別では、北米ドラッグデリバリー市場は米国、カナダ、メキシコに区分されます。2023年の北米ドラッグデリバリー市場のシェアは米国が独占しました。

Bausch Health Companies Inc.、Baxter International Inc.、Becton Dickinson and Co.、Boehringer Ingelheim International GmbH、Boston Scientific Corp、Gerresheimer AG、GlaxoSmithKline Plc、Johnson &Johnson、Kindeva Drug Delivery LP、Novartis AG、Novo Nordisk AS、Pfizer Inc、Sever Pharma Solutionsが北米ドラッグデリバリー市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 北米ドラッグデリバリー市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米ドラッグデリバリー市場-市場情勢

  • イントロダクション
  • 北米PEST分析
  • 専門家の見解

第5章 北米ドラッグデリバリー市場：主要市場力学

  • 市場促進要因
    • 慢性疾患の増加
    • 非侵襲ドラッグデリバリーに対する需要の高まり
    • 製薬会社における研究開発費の増加
  • 主な市場抑制要因
    • ドラッグデリバリーシステムの開発に伴う高コスト
    • ドラッグデリバリーにおける製品リコール
  • 主な市場機会
    • 患者のコンプライアンス向上への注力
  • 今後の動向
    • 戦略的開発と製品上市
  • 影響分析

第6章 ドラッグデリバリー市場-北米分析

  • 北米ドラッグデリバリー市場収益と予測分析

第7章 北米のドラッグデリバリー市場：収益と2028年までの予測：投与経路別

  • イントロダクション
  • 北米のドラッグデリバリー市場の投与経路別収益シェア（2022年、2028年）
  • 注射ドラッグデリバリー
  • 経口ドラッグデリバリー
  • 局所ドラッグデリバリー
  • 経粘膜ドラッグデリバリー
  • 埋め込み型ドラッグデリバリー
  • 眼科用ドラッグデリバリー

第8章 北米ドラッグデリバリー市場：収益と2028年までの予測：流通チャネル別

  • イントロダクション
  • 北米ドラッグデリバリー市場の流通チャネル別収益シェア（2022年、2028年）
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 北米ドラッグデリバリー市場：収益と2028年までの予測：エンドユーザー別

  • イントロダクション
  • 北米ドラッグデリバリー市場のエンドユーザー別収益シェア（2022年、2028年）
  • 病院およびクリニック
  • 在宅医療の現場
  • その他のエンドユーザー

第10章 北米ドラッグデリバリー市場：収益と2028年までの予測：国別分析

  • 米国
  • カナダ
  • メキシコ

第11章 北米のドラッグデリバリー市場：業界情勢

  • イントロダクション
  • 北米ドラッグデリバリー市場の成長戦略
  • 有機的成長戦略
  • 概要
  • 無機的成長戦略
  • 概要

第12章 企業プロファイル

  • Becton Dickinson and Co
  • Novo Nordisk AS
  • Boston Scientific Corp
  • Baxter International Inc
  • Gerresheimer AG
  • Kindeva Drug Delivery LP
  • GlaxoSmithKline Plc
  • Bausch Health Companies Inc
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • Sever Pharma Solutions
  • Johnson & Johnson
  • Pfizer Inc

第13章 付録

図表

List Of Tables

  • Table 1. US: North America Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. US: North America Drug Delivery Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. US: North America Drug Delivery Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US: North America Drug Delivery Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US: North America Drug Delivery Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US: North America Drug Delivery Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US: North America Drug Delivery Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
  • Table 8. US: North America Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada: North America Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada: North America Drug Delivery Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Canada: North America Drug Delivery Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Canada: North America Drug Delivery Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Canada: North America Drug Delivery Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Canada: North America Drug Delivery Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Canada: North America Drug Delivery Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Canada: North America Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Mexico: North America Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Mexico: North America Drug Delivery Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Mexico: North America Drug Delivery Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Mexico: North America Drug Delivery Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Mexico: North America Drug Delivery Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Mexico: North America Drug Delivery Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Mexico: North America Drug Delivery Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Mexico: North America Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Recent Organic Growth Strategies in North America Drug Delivery Market
  • Table 26. Recent Inorganic Growth Strategies in the North America Drug Delivery Market
  • Table 27. Glossary of Terms, North America Drug delivery market

List Of Figures

  • Figure 1. North America Drug Delivery Market Segmentation
  • Figure 2. North America Drug Delivery Market by Country
  • Figure 3. North America Drug Delivery Market Overview
  • Figure 4. Injectable Drug Delivery to Hold the Largest Share of Route of Administration Segment in North America Drug Delivery Market
  • Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. North America Drug Delivery Market Impact Analysis of Drivers and Restraints
  • Figure 9. North America Drug Delivery Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. North America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
  • Figure 11. Injectable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Conventional Injection Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Advanced Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Oral Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Liquid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Semi-solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Semi-solid Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Liquid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Solid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Transdermal Patches: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Pulmonary Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Buccal and Sublingual Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Rectal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Vaginal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Implantable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Ocular Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Eye Drops and Sprays: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Gels and Ointments: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Ocular Inserts and Punctal Plugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Therapeutic Contact Lens: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. North America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
  • Figure 35. Hospital Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Retail Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Online Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. North America Drug Delivery Systems Market Revenue Share, by End User (2022 and 2028)
  • Figure 39. Hospitals and Clinics: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Home Care Settings: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Other End User: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. North America Drug Delivery Systems Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 43. North America Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
  • Figure 44. US: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Canada: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Mexico: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Growth Strategies in North America Drug Delivery Market
目次
Product Code: BMIRE00028761

The North America drug delivery market is expected to grow from US$ 9,74,639.53 million in 2023 to US$ 14,29,417.79 million by 2028. It is estimated to register a CAGR of 8.0% from 2023 to 2028.

Rising Incidence of Chronic Diseases Fuel North America Drug Delivery Market

According to the Centers for Disease Control and Prevention (CDC), ~6 in 10 people in the US suffered from at least one chronic disease, while ~4 in 10 people had two or more chronic diseases as of 2019. Patients suffering from chronic medical conditions deteriorate with time, resulting in an enormous burden on patients' families and society. According to the projections of the American Cancer Society (ACS), the US is likely to record ~1,958,310 new cancer cases and 609,820 deaths in 2023. Diabetes is a life-threatening chronic disease with no specialized cure. All types of diabetes can lead to various complications in different body parts and increase the risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with this disease. Cases of diabetes have been increasing significantly across the globe.

The increased prevalence of chronic diseases has promoted more intensive research and development (R&D) in drug delivery systems in the past few decades. The therapeutic efficacy of drugs used to treat chronic disease can be improved with optimal drug delivery systems, such as nanoparticles (e.g., ceramic, polymeric, and metallic), micelles, liposomes, and dendrimers. Administration of a drug with a drug delivery system can also help reduce systemic side effects of drugs. Various drug delivery vehicles have been introduced for a targeted and controlled delivery of therapeutics against a wide range of chronic diseases, such as diabetes, cancer, atherosclerosis, myocardial ischemia, asthma, pulmonary tuberculosis, Parkinson's, and Alzheimer's. An appropriate drug delivery system enhances the therapeutic efficacy of any drug by ensuring high drug bioavailability for a long duration. Targeted drug delivery systems (TDDS) release drugs in a controlled manner at a preselected site in a subject's body. Nanotechnology-based delivery systems are making a significant impact on cancer treatment, and polymers play a key role in the development of these nanoparticulate carriers. In addition to the versatility of the administration route, a few of the noteworthy technological advantages of nanotherapeutic drug delivery systems (NDDS) are prolonged half-life, improved biodistribution, increased drug circulation time, controlled and sustained drug release, and elevated intercellular drug concentration.

Given the chronic nature of these conditions, patients with chronic diseases rely on continuous drug treatment, which is associated with an ongoing risk of side effects. Developing appropriate delivery systems for targeted drugs can promote the accumulation of targeted medicines in pathogenic lesions, reduce systemic side effects, and improve patient outcomes. Thus, the increasing incidences of chronic and lifestyle diseases bolster the growth of the North America drug delivery systems market.

North America Drug Delivery Market Overview

North America is the largest market for drug delivery, with the US holding the largest market share, followed by Canada. The market growth in North America is characterized by increased demand for rare disease medications from biopharmaceutical and biotechnology companies, the presence of key market players, and extensive R&D conducted by various academic and research institutes. In addition, extensive research in pharmaceutical and biotechnology companies is expected to support the growth of the drug delivery market in North America during the forecast period.

North America Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)

North America Drug Delivery Market Segmentation

The North America drug delivery market is segmented on the basis of route of administration, distribution channel, end user, and country.

Based on route of administration, the North America drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held the largest share of the North America drug delivery market in 2023.

Based on distribution channel, the North America drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the North America drug delivery market in 2023.

Based on end user, the North America drug delivery market is segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment held the largest share of the North America drug delivery market in 2023.

Based on country, the North America drug delivery market is segmented into the US, Canada, and Mexico. The US dominated the share of the North America drug delivery market in 2023.

Bausch Health Companies Inc, Baxter International Inc., Becton Dickinson and Co, Boehringer Ingelheim International GmbH, Boston Scientific Corp, Gerresheimer AG, GlaxoSmithKline Plc, Johnson & Johnson, Kindeva Drug Delivery LP, Novartis AG, Novo Nordisk AS, Pfizer Inc, and Sever Pharma Solutions are the leading companies operating in the North America drug delivery market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America drug delivery market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in North America drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Drug Delivery Market - by Route of Administration
    • 1.3.2 North America Drug Delivery Market - by Distribution Channel
    • 1.3.3 North America Drug Delivery Market - by End User
    • 1.3.4 North America Drug Delivery Market - by Country

2. North America Drug Delivery Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Drug Delivery Market - Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis
  • 4.3 Expert's Opinion

5. North America Drug Delivery Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Incidence of Chronic Diseases
    • 5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
    • 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
    • 5.2.2 Product Recalls in Drug Delivery Systems
  • 5.3 Key Market Opportunities
    • 5.3.1 Focus on Improving Patient Compliance
  • 5.4 Future Trends
    • 5.4.1 Strategic Developments and Product Launches
  • 5.5 Impact analysis

6. Drug Delivery Market - North America Analysis

  • 6.1 North America Drug Delivery Market Revenue Forecast and Analysis

7. North America Drug Delivery Market - Revenue and Forecast to 2028 - By Route of Administration

  • 7.1 Overview
  • 7.2 North America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
  • 7.3 Injectable Drug Delivery
    • 7.3.1 Overview
    • 7.3.2 Injectable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.3.2.1 Conventional Injection Devices
        • 7.3.2.1.1 Overview
        • 7.3.2.1.2 Conventional Injection Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.3.2.2 Advanced Devices
        • 7.3.2.2.1 Overview
        • 7.3.2.2.2 Advanced Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Oral Drug Delivery
    • 7.4.1 Overview
    • 7.4.2 Oral Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.2.1 Solid Oral Drugs
        • 7.4.2.1.1 Overview
        • 7.4.2.1.2 Solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.2.2 Liquid Oral Drugs
        • 7.4.2.2.1 Overview
        • 7.4.2.2.2 Liquid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.2.3 Semi-solid Oral Drugs
        • 7.4.2.3.1 Overview
        • 7.4.2.3.2 Semi-solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Topical Drug Delivery
    • 7.5.1 Overview
    • 7.5.2 Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.5.2.1 Semi-solid Topical Drug Delivery
        • 7.5.2.1.1 Overview
        • 7.5.2.1.2 Semi-solid Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.5.2.2 Liquid Topical Drug Delivery Formulations
        • 7.5.2.2.1 Overview
        • 7.5.2.2.2 Liquid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.5.2.3 Solid Topical Drug Delivery Formulations
        • 7.5.2.3.1 Overview
        • 7.5.2.3.2 Solid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.5.2.4 Transdermal
        • 7.5.2.4.1 Overview
        • 7.5.2.4.2 Transdermal Patches: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Transmucosal Drug Delivery
    • 7.6.1 Overview
    • 7.6.2 Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.6.2.1 Pulmonary and Nasal Drug Delivery
        • 7.6.2.1.1 Overview
        • 7.6.2.1.2 Pulmonary and Nasal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.6.2.2 Buccal and Sublingual Drug Delivery
        • 7.6.2.2.1 Overview
        • 7.6.2.2.2 Buccal and Sublingual Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.6.2.3 Rectal Transmucosal Drug Delivery
        • 7.6.2.3.1 Overview
        • 7.6.2.3.2 Rectal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.6.2.4 Vaginal Transmucosal Drug Delivery
        • 7.6.2.4.1 Overview
        • 7.6.2.4.2 Vaginal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Implantable Drug Delivery
    • 7.7.1 Overview
    • 7.7.2 Implantable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Ocular Drug Delivery
    • 7.8.1 Overview
    • 7.8.2 Ocular Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.8.2.1 Eye Drops and Sprays
        • 7.8.2.1.1 Overview
        • 7.8.2.1.2 Eye Drops and Sprays: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.8.2.2 Gels and Ointments
        • 7.8.2.2.1 Overview
        • 7.8.2.2.2 Gels and Ointments: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.8.2.3 Ocular Inserts and Punctal Plugs
        • 7.8.2.3.1 Overview
        • 7.8.2.3.2 Ocular Inserts and Punctal Plugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.8.2.4 Therapeutic Contact Lens
        • 7.8.2.4.1 Overview
        • 7.8.2.4.2 Therapeutic Contact Lens: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Drug Delivery Market - Revenue and Forecast to 2028 - By Distribution Channel

  • 8.1 Overview
  • 8.2 North America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
  • 8.3 Hospital Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Hospital Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Retail Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Retail Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Online Pharmacies
    • 8.5.1 Overview
    • 8.5.2 Online Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Drug Delivery Market - Revenue and Forecast to 2028 - By End User

  • 9.1 Overview
  • 9.2 North America Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Home Care Settings
    • 9.4.1 Overview
    • 9.4.2 Home Care Settings: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Other End User
    • 9.5.1 Overview
    • 9.5.2 Other End User: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Drug Delivery Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Overview
    • 10.1.1 North America Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
      • 10.1.1.1 US: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 US: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 US: North America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
        • 10.1.1.1.3.1 US: North America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.1.3.2 US: North America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.1.3.3 US: North America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.1.3.4 US: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.1.3.5 US: North America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.1.4 US: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
        • 10.1.1.1.5 US: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.2 Canada: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 Canada: North America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
        • 10.1.1.2.3.1 Canada: North America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.2.3.2 Canada: North America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.2.3.3 Canada: North America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.2.3.4 Canada: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.2.3.5 Canada: North America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.2.4 Canada: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
        • 10.1.1.2.5 Canada: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)
      • 10.1.1.3 Mexico: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 Mexico: North America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
        • 10.1.1.3.3.1 Mexico: North America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.3.3.2 Mexico: North America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.3.3.3 Mexico: North America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.3.3.4 Mexico: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.3.3.5 Mexico: North America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
        • 10.1.1.3.4 Mexico: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
        • 10.1.1.3.5 Mexico: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)

11. North America Drug Delivery Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in North America Drug Delivery Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Becton Dickinson and Co
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Novo Nordisk AS
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Boston Scientific Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Baxter International Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Gerresheimer AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Kindeva Drug Delivery LP
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 GlaxoSmithKline Plc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
      • 12.7.5.1 Key Developments
  • 12.8 Bausch Health Companies Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Boehringer Ingelheim International GmbH
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Novartis AG
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Sever Pharma Solutions
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Johnson & Johnson
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Pfizer Inc
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms